Trial Profile

The first-in-human, phase 1b trial in patients with acute ischemic stroke

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 06 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

03 Jun 2024 According to an Aruna Bio media release, company is expected to start this trial in the second half of 2024.
16 Jan 2024 According to an Aruna Bio media release, the trial is is expected to initiate in the first half of 2024.
16 Jan 2024 According to an Aruna Bio media release, company announced that announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of lead program, AB126.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com